BAXTER INTERNATIONAL INC — Director's Dealing 2013

Feb 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KALOBIOS PHARMACEUTICALS INC (KBIO)
CIK: 0001293310
Period of Report: 2013-02-05

Reporting Person: BAXTER INTERNATIONAL INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-05	Common Stock	C	958583	—	Acquired	958583	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-05	Series D Preferred Stock	$	C	842435	Disposed		Common Stock (958583)	Direct

Footnotes

F1: Each share of Series D Preferred Stock automatically converted into approximately 1.14 shares of Common Stock, including applicable anti-dilution adjustments, in connection with the consummation of Issuer's initial public offering.

F2: Reflects 1-for-3.56147 reverse stock split which became effective on January 15, 2013.

F3: No expiration date.